Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
GSK breaks up with BIO for 2025 - fiercepharma.com
Nov 8, 2024 · GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), following a string of exits by companies including Pfizer, UCB, WuXi AppTec and ...
CDMO Resilience plots 105 layoffs at Florida plant it acquired in …
Dec 6, 2024 · The CDMO originally got its hands on the Alachua facility—and some 300 new employees—when it acquired biologic drug substance maker Ology Bioservices for an undisclosed sum back in April 2021 ...
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
Pharma | Fierce Pharma
Eli Lilly has operated a global capability center in Bengaluru, India, since 2016. Now the company is setting up a similar site in Hyderabad.
2024 approvals: Biopharma delivered 55 new drugs, biologics
Jan 2, 2025 · The FDA signed off on 55 new drugs in 2024, down from 60-plus in 2023.
FDA panel says more testing needed to solve Moderna trial halt
Dec 13, 2024 · An FDA panel—examining the halt of a Moderna RSV vaccine trial—echoed frustration in knowledge gaps about RSV and said that more testing is needed.
Trump names Andrew Ferguson as pick for FTC chair in potential …
Dec 11, 2024 · Notably, the FTC in 2021 said it would work with the Justice Department, state attorneys general and competition authorities in other countries to scrutinize the market results of major biopharma ...
Pfizer’s latest Viagra TV ad pitches mobile texting for discounts
Jan 19, 2017 · In the case of Viagra, texting the savings code results in a message that requires consumers to first reply “Yes” to opt into the program and agree to “terms and complete enrollment.”
Autolus enters CAR-T race with FDA approval for Aucatzyl
Nov 11, 2024 · Watch out, Gilead and Novartis: there's a new CAR-T in town. Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl, a late entry to the heated CD19 CAR-T cell ...